publications
Experimental Drug Yields Dramatic Weight Loss
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.
Read full story on NY Times → More top storiesAlso covered by
MarketWatch
Lilly’s new experimental shot produced 28% weight loss
CNBC
Eli Lilly says next-generation weight loss drug clears crucial obesity trial
STAT News
STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial
Healthline
‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound?
Aggregated and edited by the Scoop newsroom. We surface news from NY Times alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop